JohnFPaoliniMDPhD

Cardiology • Lexington, MA

Chief Medical Officer

Join to view full profile

Dr. Paolini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Paolini's full profile

Already have an account?

Office
100 Hayden Ave
Lexington, MA 02421

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1997 - 2001
Duke University School of MedicineClass of 1995

Certifications & Licensure

PA State Medical License 2001 - 2012

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

A Pilot Study of KPL-914 in Recurrent Pericarditis Start of enrollment: 2018 Jan 24
Completed
Phase 2

Publications & Presentations

PubMed

Longitudinal cardiac magnetic resonance imaging following clinical response to rilonacept and prior to recurrence upon treatment suspension: a RHAPSODY subgroup analysis.
Paul C Cremer, Antonio Brucato, Antonella Insalaco, David Lin, Sushil A Luis
European Heart Journal. Cardiovascular Imaging. 2024-08-22
2 citations
Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension.
Antonio Brucato, Lucia Trotta, Michael Arad, Paul C Cremer, Antonella Insalaco
CJC Open. 2024-06-01
9 citations
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
Massimo Imazio, Allan L Klein, Antonio Brucato, Antonio Abbate, Michael Arad
Journal of the American Heart Association. 2024-03-19

Journal Articles

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
Allan L Klein, Paul Cremer, Martin Lewinter, Sushil A Luis, John F Paolini, The New England Journal of Medicine

Press Mentions

Kiniksa Announces Lancet Rheumatology Publication of Clinical Outcomes with Mavrilimumab in COVID-19June 17th, 2020
Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical TrialDecember 12th, 2018
New Agent Prevents Stroke in Patients with Atrial Fibrillation, Study SuggestsAugust 10th, 2011
Join now to see all